Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer - Archive ouverte HAL Access content directly
Journal Articles Clinical Cancer Research Year : 2010

Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer

(1) , (2) , (3) , (4) , (3) , (3) , (5) , (6) , (6) , (6) , (4) , (7) , (3) , (1) , (3)
1
2
3
4
5
6
7

Abstract

Purpose: This study aimed to investigate the role of the neurotensin/neurotensin receptor I (NTSR1) complex in non-small cell lung cancer (NSCLC) progression. Experimental Design: The expression of neurotensin and NTSR1 was studied by transcriptome analysis and immunohistochemistry in two series of 74 and 139 consecutive patients with pathologic stage I NSCLC adenocarcinoma. The findings were correlated with clinic-pathologic features. Experimental tumors were generated from the malignant human lung carcinoma cell line A459, and a subclone of LNM35, LNM-R. The role of the neurotensin signaling system on tumor growth and metastasis was investigated by small hairpin RNA-mediated silencing of NTSR1 and neurotensin. Results: Transcriptome analysis carried out in a series of 74 patients showed that the positive regulation of NTSR1 put it within the top 50 genes related with relapse-free survival. Immunohistochemistry revealed neurotensin-and NTSR1-positive staining in 60.4% and 59.7% of lung adenocarcinomas, respectively. At univariate analysis, NTSR1 expression was strongly associated with worse 5-year overall survival rate (P = 0.0081) and relapse-free survival (P = 0.0024). Multivariate analysis showed that patients over 65 years of age (P = 0.0018) and NTSR1 expression (P = 0.0034) were independent negative prognostic factors. Experimental tumor xenografts generated by neurotensin-and NTSR1-silenced human lung cancer cells revealed that neurotensin enhanced primary tumor growth and production of massive nodal metastasis via autocrine and paracrine regulation loops. Conclusion: NTSR1 expression was identified as a potential new prognostic biomarker for surgically resected stage I lung adenocarcinomas, as NTSR1 activation was shown to participate in lung cancer progression.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02459564 , version 1 (29-01-2020)

Identifiers

Cite

Marco Alifano, Frédérique Souazé, Sandra Dupouy, Sophie Camilleri-Broët, Mohamad Younes, et al.. Neurotensin Receptor 1 Determines the Outcome of Non-Small Cell Lung Cancer. Clinical Cancer Research, 2010, 16 (17), pp.4401-4410. ⟨10.1158/1078-0432.CCR-10-0659⟩. ⟨inserm-02459564⟩
73 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More